Spero Health Erlanger

Spero Health Erlanger

Services:
Ancillary Services
• Suicide prevention services
• Social skills development
• Case management service
• Early intervention for HIV
• Mental health services

Transitional Services

• Outcome follow-up after discharge
• Naloxone and overdose education
• Discharge Planning
• Aftercare/continuing care

Opioid Medications used in Treatment

• Buprenorphine used in Treatment
• Naltrexone used in Treatment

Type of Alcohol Use Disorder Treatment

• Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
• This facility administers/prescribes medication for alcohol use disorder

Facility Vaping Policy

• Vaping permitted in designated area

Testing

• HIV testing
• Testing for Hepatitis C (HCV)
• Drug and alcohol oral fluid testing
• Breathalyzer or blood alcohol testing
• Testing for Hepatitis B (HBV)
• Drug or alcohol urine screening
• STD testing
• TB screening

License/Certification/Accreditation

• Commission on Accreditation of Rehabilitation Facilities (CARF)

Facility Smoking Policy

• Smoking permitted in designated area

Payment/Insurance/Funding Accepted

• Medicaid
• Federal military insurance (e.g., TRICARE)
• Cash or self-payment
• Private health insurance
• Medicare

Pharmacotherapies

• Medication for mental disorders
• Buprenorphine without naloxone
• Clonidine
• Medications for Hepatitis C treatment
• Buprenorphine (extended-release, injectable)
• Buprenorphine with naloxone
• Nicotine replacement
• Naltrexone (extended-release, injectable)
• Buprenorphine sub-dermal implant
• Naltrexone (oral)

Education and Counseling Services

• Smoking/vaping/tobacco cessation counseling
• Individual counseling
• Hepatitis education, counseling, or support
• Substance use disorder education
• Health education services other than HIV/AIDS or hepatitis
• Group counseling
• HIV or AIDS education, counseling, or support

Age Groups Accepted

• Young Adults
• Adults

Special Programs/Groups Offered

• Clients with HIV or AIDS
• Clients who have experienced intimate partner violence, domestic violence
• Clients with co-occurring pain and substance use disorders
• Clients who have experienced trauma
• Clients with co-occurring mental and substance use disorders
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
• Criminal justice (other than DUI/DWI)/Forensic clients
• Seniors or older adults
• Pregnant/postpartum women
• Adult women
• Adult men
• Clients who have experienced sexual abuse

Type of Opioid Treatment

• Prescribes naltrexone
• Prescribes buprenorphine
• Relapse prevention with naltrexone
• Buprenorphine maintenance

External Source of Medications Used for Alcohol Use Disorder Treatment

• In-network prescribing entity

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment
• Outpatient

Type of Care

• Substance use treatment

Assessment/Pre-treatment

• Screening for tobacco use
• Outreach to persons in the community
• Comprehensive substance use assessment
• Screening for mental disorders
• Comprehensive mental health assessment
• Professional interventionist/educational consultant
• Complete medical history/physical exam
• Screening for substance use

Recovery Support Services

• Mentoring/peer support
• Employment counseling or training
• Recovery coach
• Housing services
• Assistance with obtaining social services

Gender Accepted

• Female
• Male

Treatment Approaches

• Contingency management/motivational incentives
• Trauma-related counseling
• Telemedicine/telehealth therapy
• Anger management
• Substance use disorder counseling
• Matrix Model
• Cognitive behavioral therapy
• Brief intervention
• Relapse prevention
• Motivational interviewing